Billing & Coding

Billing & Coding

Billing & Coding

Written by William ‘Brad’ Howard, CPC, CMPA, CHONC, CIRCC

Eligible Patient Populations

  • Patients aged 50-77 years (For Medicare, commercial plans may accept 50-80)

    • Asymptomatic for lung cancer

    • Current Smokers or Former Smokers who have quit within the last 15 years

    • At least 20 pack-years smoking history

      • Pack-years = (packs smoked per day) × (years as a smoker); 1 pack =20 cigarettes

  • Patients aged 50-77 years (For Medicare, commercial plans may accept 50-80)

    • Asymptomatic for lung cancer

    • Current Smokers or Former Smokers who have quit within the last 15 years

    • At least 20 pack-years smoking history

      • Pack-years = (packs smoked per day) × (years as a smoker); 1 pack =20 cigarettes

  • Patients aged 50-77 years (For Medicare, commercial plans may accept 50-80)

    • Asymptomatic for lung cancer

    • Current Smokers or Former Smokers who have quit within the last 15 years

    • At least 20 pack-years smoking history

      • Pack-years = (packs smoked per day) × (years as a smoker); 1 pack =20 cigarettes

Counseling Visit

  • Prior to lung cancer screening via LDCT, a face-to-face counseling visit with the patient must occur

    • Screening must be ordered and documented by a licensed practitioner (physician, PA, NP)

    • Screening visits can be provided by auxiliary personnel, incident-to the licensed practitioner’s initial treatment plan

    • Can be performed in-office or via telehealth

    • Can be performed with a separately identifiable E/M visit (e.g., Annual Wellness Visit)

    • Can be performed more than once a year

  • Documentation in the medical record to support counseling visit should include the following:

    • Counseling on the following topics:

      • Importance of adhering to annual LDCT screenings

      • Ability and willingness to undergo potential treatment for a confirmed diagnosis

      • Impact of any comorbidities

      • Smoking cessation interventions and services (for active smokers)

        • Smoking cessation is billable during the same encounter as a separately identifiable E/M visit

        • Time specific to cessation counseling should be documented

      • Shared decision-making using one or more interactive decision aids

        • Shared decision-making describes a two-way discussion between the provider and patient on available options for screenings, risks and expected outcomes, as well as patient preferences and values

        • Decision aids describe educational literature, handouts, videos, or web-based tools that outline the potential benefits, risks, and uncertainties of LDCT screenings

      • Patient decision on whether to proceed with screening

      • Treatment plan for screening if ordered

      • Order for LDCT screening can be written or entered electronically

  • Prior to lung cancer screening via LDCT, a face-to-face counseling visit with the patient must occur

    • Screening must be ordered and documented by a licensed practitioner (physician, PA, NP)

    • Screening visits can be provided by auxiliary personnel, incident-to the licensed practitioner’s initial treatment plan

    • Can be performed in-office or via telehealth

    • Can be performed with a separately identifiable E/M visit (e.g., Annual Wellness Visit)

    • Can be performed more than once a year

  • Documentation in the medical record to support counseling visit should include the following:

    • Counseling on the following topics:

      • Importance of adhering to annual LDCT screenings

      • Ability and willingness to undergo potential treatment for a confirmed diagnosis

      • Impact of any comorbidities

      • Smoking cessation interventions and services (for active smokers)

        • Smoking cessation is billable during the same encounter as a separately identifiable E/M visit

        • Time specific to cessation counseling should be documented

      • Shared decision-making using one or more interactive decision aids

        • Shared decision-making describes a two-way discussion between the provider and patient on available options for screenings, risks and expected outcomes, as well as patient preferences and values

        • Decision aids describe educational literature, handouts, videos, or web-based tools that outline the potential benefits, risks, and uncertainties of LDCT screenings

      • Patient decision on whether to proceed with screening

      • Treatment plan for screening if ordered

      • Order for LDCT screening can be written or entered electronically

  • Prior to lung cancer screening via LDCT, a face-to-face counseling visit with the patient must occur

    • Screening must be ordered and documented by a licensed practitioner (physician, PA, NP)

    • Screening visits can be provided by auxiliary personnel, incident-to the licensed practitioner’s initial treatment plan

    • Can be performed in-office or via telehealth

    • Can be performed with a separately identifiable E/M visit (e.g., Annual Wellness Visit)

    • Can be performed more than once a year

  • Documentation in the medical record to support counseling visit should include the following:

    • Counseling on the following topics:

      • Importance of adhering to annual LDCT screenings

      • Ability and willingness to undergo potential treatment for a confirmed diagnosis

      • Impact of any comorbidities

      • Smoking cessation interventions and services (for active smokers)

        • Smoking cessation is billable during the same encounter as a separately identifiable E/M visit

        • Time specific to cessation counseling should be documented

      • Shared decision-making using one or more interactive decision aids

        • Shared decision-making describes a two-way discussion between the provider and patient on available options for screenings, risks and expected outcomes, as well as patient preferences and values

        • Decision aids describe educational literature, handouts, videos, or web-based tools that outline the potential benefits, risks, and uncertainties of LDCT screenings

      • Patient decision on whether to proceed with screening

      • Treatment plan for screening if ordered

      • Order for LDCT screening can be written or entered electronically

Billing

  • Pre-authorization is not required for traditional Medicare patients

  • Pre-authorization may or may not be required for Medicare Advantage, Medicaid, and commercial plans

  • Shared decision-making visit can be reported using HCPCS code G0296 (Counseling visit to discuss need for lung cancer screening using LDCT)

    • Append modifier -95 if performed via telehealth

    • Append modifier -25 to any separately identifiable E/M visit on same date-of-service

    • No patient copay

  • LDCT screening can be reported using:

    • CPT code 71271 (Computed tomography, thorax, low dose for lung cancer screening, without contrast material(s)

    • No patient copay

  • Recommended ICD-10 diagnosis codes for G0296 and 71271 (depending on documentation of smoking status):

    • Z87.891 (Personal history of nicotine dependence)

    • F17.210 (Nicotine dependence, cigarettes, uncomplicated)

    • F17.211 (Nicotine dependence, cigarettes, in remission)

    • F17.213 (Nicotine dependence, cigarettes, with withdrawal)

    • F17.218 (Nicotine dependence, cigarettes, with other nicotine-induced disorders)

    • F17.219 (Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders)

  • Smoking cessation counseling for active smokers can be reported using:

    • 99406 (4-10 minutes of counseling)

    • 99407 (More than 10 minutes of counseling)

      • Append modifier -95 if performed via telehealth

      • Diagnosis code F17.210 (Nicotine dependence, cigarettes, uncomplicated)

    • Append modifier -25 to any separately identifiable E/M visit on same date-of-service

  • Pre-authorization is not required for traditional Medicare patients

  • Pre-authorization may or may not be required for Medicare Advantage, Medicaid, and commercial plans

  • Shared decision-making visit can be reported using HCPCS code G0296 (Counseling visit to discuss need for lung cancer screening using LDCT)

    • Append modifier -95 if performed via telehealth

    • Append modifier -25 to any separately identifiable E/M visit on same date-of-service

    • No patient copay

  • LDCT screening can be reported using:

    • CPT code 71271 (Computed tomography, thorax, low dose for lung cancer screening, without contrast material(s)

    • No patient copay

  • Recommended ICD-10 diagnosis codes for G0296 and 71271 (depending on documentation of smoking status):

    • Z87.891 (Personal history of nicotine dependence)

    • F17.210 (Nicotine dependence, cigarettes, uncomplicated)

    • F17.211 (Nicotine dependence, cigarettes, in remission)

    • F17.213 (Nicotine dependence, cigarettes, with withdrawal)

    • F17.218 (Nicotine dependence, cigarettes, with other nicotine-induced disorders)

    • F17.219 (Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders)

  • Smoking cessation counseling for active smokers can be reported using:

    • 99406 (4-10 minutes of counseling)

    • 99407 (More than 10 minutes of counseling)

      • Append modifier -95 if performed via telehealth

      • Diagnosis code F17.210 (Nicotine dependence, cigarettes, uncomplicated)

    • Append modifier -25 to any separately identifiable E/M visit on same date-of-service

  • Pre-authorization is not required for traditional Medicare patients

  • Pre-authorization may or may not be required for Medicare Advantage, Medicaid, and commercial plans

  • Shared decision-making visit can be reported using HCPCS code G0296 (Counseling visit to discuss need for lung cancer screening using LDCT)

    • Append modifier -95 if performed via telehealth

    • Append modifier -25 to any separately identifiable E/M visit on same date-of-service

    • No patient copay

  • LDCT screening can be reported using:

    • CPT code 71271 (Computed tomography, thorax, low dose for lung cancer screening, without contrast material(s)

    • No patient copay

  • Recommended ICD-10 diagnosis codes for G0296 and 71271 (depending on documentation of smoking status):

    • Z87.891 (Personal history of nicotine dependence)

    • F17.210 (Nicotine dependence, cigarettes, uncomplicated)

    • F17.211 (Nicotine dependence, cigarettes, in remission)

    • F17.213 (Nicotine dependence, cigarettes, with withdrawal)

    • F17.218 (Nicotine dependence, cigarettes, with other nicotine-induced disorders)

    • F17.219 (Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders)

  • Smoking cessation counseling for active smokers can be reported using:

    • 99406 (4-10 minutes of counseling)

    • 99407 (More than 10 minutes of counseling)

      • Append modifier -95 if performed via telehealth

      • Diagnosis code F17.210 (Nicotine dependence, cigarettes, uncomplicated)

    • Append modifier -25 to any separately identifiable E/M visit on same date-of-service

Abnormal Findings From LDCT Screening

  • Interval chest CT or CTA may be required following abnormal LDCT screening results

  • This is a diagnostic study performed off-cycle from annual LDCT screenings

  • Co-pay may be required

  • Report CT using 71250 (Computed tomography, diagnostic; without contrast material)

  • Report CTA using 71275 (Computed tomography angiography, chest (non-coronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing)

  • If lung cancer diagnosis is confirmed patient should be removed from future lung cancer screenings

    • Patient may be re-admitted to LDCT screening treatment plan following completed treatment of lung cancer

  • Interval chest CT or CTA may be required following abnormal LDCT screening results

  • This is a diagnostic study performed off-cycle from annual LDCT screenings

  • Co-pay may be required

  • Report CT using 71250 (Computed tomography, diagnostic; without contrast material)

  • Report CTA using 71275 (Computed tomography angiography, chest (non-coronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing)

  • If lung cancer diagnosis is confirmed patient should be removed from future lung cancer screenings

    • Patient may be re-admitted to LDCT screening treatment plan following completed treatment of lung cancer

  • Interval chest CT or CTA may be required following abnormal LDCT screening results

  • This is a diagnostic study performed off-cycle from annual LDCT screenings

  • Co-pay may be required

  • Report CT using 71250 (Computed tomography, diagnostic; without contrast material)

  • Report CTA using 71275 (Computed tomography angiography, chest (non-coronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing)

  • If lung cancer diagnosis is confirmed patient should be removed from future lung cancer screenings

    • Patient may be re-admitted to LDCT screening treatment plan following completed treatment of lung cancer

FAQs

Can the shared decision-making visit (G0296) occur on the same day as the lung cancer screening CT (71271)?

Can the shared decision-making visit (G0296) occur on the same day as the lung cancer screening CT (71271)?

Can the shared decision-making visit (G0296) occur on the same day as the lung cancer screening CT (71271)?

Can the shared decision-making visit (G0296) occur on the same day as the lung cancer screening CT (71271)?

Do different Lung-RADS categories affect coding of subsequent scans?

Do different Lung-RADS categories affect coding of subsequent scans?

Do different Lung-RADS categories affect coding of subsequent scans?

Do different Lung-RADS categories affect coding of subsequent scans?